The products reported missing include insulin formulations marketed as Ryzodeg FlexTouch and Fiasp (Penfill and FlexTouch), ...

Lucknow: In a new trend, people with obesity are using injections originally prescribed for diabetics to lose weight.Doctors ...

Miracle weight loss jabs could help ward off up to 12 obesity-related cancers, but world-leading experts are hesitant to ...

Shares of Viking Therapeutics VKTX plunged 36% in the past week after it reported mixed top-line results from a mid-stage study evaluating the safety and efficacy of the oral formulation of its ...

The sNDA for acquired hyothalamic obesity is supported by data from the randomized, double-blind, placebo-controlled phase 3 TRANSCEND trial.

When bad news drops, investors have a tendency to sell first and ask questions later. Let's take a closer look at why Viking ...

A rumor that pharmaceutical companies behind popular weight-loss and diabetes medications like Ozempic faced lawsuits ...

New pill orforglipron was associated with a significant reduction in body weight and better cholesterol, triglycerides and blood pressure.

Shares in Viking Therapeutics have lost more than 40% of their value after it reported phase 2 results that showed that its ...

Obesity and overweight increase the risk of type 2 diabetes, hypertension, cardiovascular disease and stroke. The quality of ...

Last year, GLP-1s dominated many employer conversations as demand surged and pressure mounted from employees clamoring for ...

Viking's obesity pill VK2735 met its primary endpoint but failed to outdo competitors Novo Nordisk and Eli Lilly in body ...